What causes elevated total and free testosterone levels in a post-hysterectomy (surgical removal of the uterus) 60-year-old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated Testosterone in a Post-Hysterectomy 60-Year-Old Female

Elevated total and free testosterone in a 60-year-old female who has had a hysterectomy is most likely due to an androgen-secreting tumor, particularly ovarian stromal hyperplasia or an adrenal adenoma, which requires immediate evaluation to rule out malignancy.

Diagnostic Approach

Initial Laboratory Evaluation

  • Confirm elevated testosterone levels with repeat testing
  • Measure additional hormones:
    • Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) 1
    • Sex hormone-binding globulin (SHBG) 1
    • Dehydroepiandrosterone sulfate (DHEAS) 2
    • Androstenedione 2
    • Estradiol 1
    • Prolactin (if LH/FSH are low or low-normal) 1
    • Inhibin B 2

Most Common Causes in Post-Hysterectomy Women

  1. Ovarian sources (if ovaries were preserved):

    • Ovarian stromal hyperplasia/hyperthecosis 2, 3
    • Ovarian androgen-secreting tumors (0.5% of all ovarian tumors) 2
    • Lipid cell tumors 4
    • Hilar cell hyperplasia 5
  2. Adrenal sources:

    • Adrenal adenomas 5
    • Adrenal carcinomas (less common than ovarian tumors) 2
  3. Other causes:

    • Ectopic testosterone-producing tissue (residual ovarian tissue or from primitive mesenchymal cells) 5
    • Exogenous testosterone or anabolic steroid use 6
    • Undiagnosed polycystic ovary syndrome worsening after menopause 2
    • Congenital adrenal hyperplasia 2
    • Cushing syndrome 2

Imaging Studies

  • MRI of adrenal glands and pelvis (if ovaries were preserved) 2
  • CT scan of abdomen and pelvis if MRI is not available
  • Transvaginal ultrasound (if ovaries were preserved)

Special Diagnostic Tests

  • Overnight dexamethasone suppression test to differentiate adrenal from ovarian sources 3
  • ACTH stimulation test if adrenal source is suspected 5
  • GnRH agonist test (nafarelin) if gonadotropin-responsive tissue is suspected 5

Management Considerations

For Ovarian Source (if ovaries were preserved):

  • Bilateral oophorectomy is recommended for confirmed ovarian hyperplasia or tumors 3
  • Post-surgical follow-up with testosterone levels to confirm resolution

For Adrenal Source:

  • Laparoscopic adrenalectomy for confirmed adrenal adenomas 5
  • Referral to oncology for suspected adrenal carcinoma

For Unidentified Source:

  • GnRH agonist/analogues or antagonists may be effective for unidentified sources 2
  • Medical management with anti-androgens may be considered for patients unfit for surgery

Important Considerations

  • Elevated testosterone in postmenopausal women increases risk for hypercholesterolemia, insulin resistance, hypertension, and cardiac disease 2
  • Peripheral aromatization of excess androgens may increase estrogen levels, raising endometrial cancer risk if uterus is intact 3
  • Persistent elevation after initial treatment warrants further investigation for additional or ectopic sources 5

Follow-up

  • Monitor testosterone levels post-treatment to confirm resolution
  • Assess for improvement in clinical symptoms (hirsutism, alopecia, etc.)
  • Consider hormone replacement therapy after definitive treatment if indicated 6

Remember that elevated testosterone in a postmenopausal woman, especially with clinical manifestations of hyperandrogenism, should never be considered normal and requires thorough evaluation to exclude potentially serious underlying causes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Postmenopausal hyperandrogenism.

Climacteric : the journal of the International Menopause Society, 2022

Research

A benign cause of hyperandrogenism in a postmenopausal woman.

Endocrinology, diabetes & metabolism case reports, 2021

Research

[A case of postmenopausal hyperandrogenism caused by a lipid cell tumor].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 2002

Research

The case of the elusive androgen.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2002

Guideline

Hormone Replacement Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.